UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000023312
Receipt No. R000026861
Official scientific title of the study Effects of budesonide/formoterol in COPD patients with eosinophilic airway inflammation
Date of disclosure of the study information 2016/07/26
Last modified on 2017/07/25 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Effects of budesonide/formoterol in COPD patients with eosinophilic airway inflammation
Title of the study (Brief title) Effects of budesonide/formoterol in COPD patients with eosinophilic airway inflammation
Region
Japan

Condition
Condition CPOD
Classification by specialty
Pneumology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To evaluate the efficacy of inhaled budesonide/formoterol combination in COPD patients with eosinophilic airway inflammation.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Change in FEV1 between week 0 and week 8.
Key secondary outcomes Change in FVC between week 0 and week 8
Change in FEV1/FVC between week 0 and week 8
Change in FOT parameters between week 0 and week 8
Change in CAT between week 0 and week 8
Change in mMRC between week 0 and week 8
Change in FeNO between week 0 and week 8
Change in sputum eosinophils between week 0 and week 8

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Additive administration of budesonide/formoterol
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
40 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1) A Patient who is visiting our outpatient clinic, is over 40 years of age, and has smoking history
2) A patient who smoke 1 pack per day for 10 years or more
3) A patient who agreed to participate in the study with the written informed consent
4) A patients who have FeNO >35 ppb or sputum eosinophils >3%
Key exclusion criteria 1) A Patients with asthma.
2) A patients who have has experienced an acute COPD exacerbation or respiratory tract infection within the past 12 weeks prior to the informed consent
3) A patients receiving oxygen inhalation
4) A patient whom the doctor in charge judged unsuitable as subjected is excluded.
Target sample size 30

Research contact person
Name of lead principal investigator Taisuke Akamatsu
Organization Shizuoka General Hospital
Division name Department of Respiratory Medicine
Address 4-27-1 Kita-Ando, Aoi, Shizuoka, 420-8527, Japan
TEL 054-247-6111
Email taisuke-akamatsu@i.shizuoka-pho.jp

Public contact
Name of contact person Taisuke Akamatsu
Organization Shizuoka General Hospital
Division name Department of Respiratory Medicine
Address 4-27-1 Kita-Ando, Aoi, Shizuoka, 420-8527, Japan
TEL 054-247-6111
Homepage URL
Email taisuke-akamatsu@i.shizuoka-pho.jp

Sponsor
Institute Department of Respiratory Medicine, Shizuoka General Hospital
Institute
Department

Funding Source
Organization none
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2016 Year 07 Month 26 Day

Progress
Recruitment status Completed
Date of protocol fixation
2016 Year 06 Month 01 Day
Anticipated trial start date
2016 Year 07 Month 26 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2016 Year 07 Month 24 Day
Last modified on
2017 Year 07 Month 25 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000026861